 |
News Releases
The following news releases have been issued since July 17,
1996. Please note that news releases are posted to this site within 24 hours of
release.
You may want to search for topics
by keyword.
- 1998
- November 11, 1998
- Third Quarter Results Reported
-
- November 10, 1998
- OP-1 is Effective 3 Days after Stroke in Preclinical Studies
-
- October 16, 1998
- Company Sells OP-1 Manufacturing to Stryker
- October 6, 1998
- Company and the University of Colorado School of Medicine Receive
Grant from NIH for Parkinson's Research
-
- October 5, 1998
- Company Modifies its Renal Disease Partnership with
Biogen
-
- September 22, 1998
- Company and The Miami Project to Cure Paralysis
Partner to Develop New Treatments for Brain and Spinal Cord Injury
- August 20, 1998
- Company and Stryker Respond to Hart-Scott-Rodino Filing Disclosure
- August 10, 1998
- Second Quarter Results Reported
-
- June 30, 1998
- Creative BioMolecules and Stryker Update Modular PMA Status of
OP-1 Bone Graft Device
-
- May 29, 1998
- Company Raises $25 Million to Enhance Product
Pipeline
-
- May 14, 1998
- First Quarter Results Reported
-
- March 23, 1998
- OP-1 Clinical Trial Data Presented at American
Academy of Orthopaedic Surgeons
-
- March 11, 1998
- 1997 Year End Results Reported
- 1997
- November 14, 1997
- Carl M. Cohen, PhD, Appointed to a New Position of Vice President,
Research
-
- November 7, 1997
- Third Quarter Results Reported
- OP-1 Protects Against Damage Caused by Kidney Failure
-
- October 30, 1997
- OP-1 Is Involved in the Development and Function of Neurons
-
- October 28, 1997
- OP-1 Enhances Recovery from Stroke in Preclinical Models
-
- August 8, 1997
- Second Quarter Results Reported
-
- July 28, 1997
- OP-1 Role in Neurological Development Reported in Studies
Published in Cell
-
- July 16, 1997
- Research Shows That OP-1 May Play an Important Role in the
Treatment of Stroke
-
- July 9, 1997
- Five New Members Appointed to Management Team
-
- May 14, 1997
- First Quarter Result Reported
-
- March 11, 1997
- Suzanne Denbo Jaffe Appointed to Board of Directors
-
- February 27, 1997
- New Members Appointed to Management Team
-
- February 26, 1997
- 1996 Year End Results Reported
- February 13, 1997
- Preliminary Data on OP-1 Device Reported at American Academy of
Orthopaedic Surgeons
- January 8, 1997
- Company Presents at 15th Annual Hambrecht
& Quist Healthcare Conference
-
- January 6, 1997
- Company Closes Biogen Renal Deal; Receives $28 Million Payment
-
- 1996
-
- December 10, 1996
- Company Closes Renal Deal with Biogen, Inc. and Receives $28
Million Payment
-
- November 14, 1996
- Company Announces Dental Agreement with Stryker
-
- November 12, 1996
- Third Quarter Results Reported
-
- November 4, 1996
- OP-1 Protects Against Kidney Damage in Models of Acute and Chronic
Renal Failure
-
- August 20, 1996
- OP-1 is Critical Signaling Molecule in Kidney Development, Reports
Proceedings of the National
Academy of Sciences
-
- August 15, 1996
- Second Quarter Results Reported
-
- July 17, 1996
- Company Announces Cross-License Agreement with Stryker and
Genetics Institute
Copyright 1998 Creative BioMolecules, Inc. All Rights
Reserved
Last modified: 03/12/99
|
